GeneChem Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 3

Professionals

  • Investments
  • 91

  • Portfolio
  • 9

  • Exits
  • 54

Exits

GeneChem General Information

Company Description

Founded in 1997, GeneChem is a venture capital firm based in Montreal, Canada. The firm seeks to invest in United States, Canada, and Europe-based companies operating in the drug discovery and development sector.

Business Details

Year Founded
1997
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Mezzanine
Corporate Office
  • 1, Westmount Square
  • Suite 800
  • Montreal, Quebec H3Z 2P9
  • Canada
+1 (514) 000-0000

GeneChem Investments (91)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Giiant Pharma 30-Jun-2021 Seed Round 000.00 Drug Discovery Pre-Clinical Trials 000000 000000 00.0
Inversago Pharma 08-Sep-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 000000 000000 00.0
Neurasic Therapeutics 25-Mar-2020 00000 00000 00.000 Drug Discovery Generating Revenue 000000 000000 00.0
MyX Therapeutics 09-Oct-2018 0000 00000 00000 Drug Delivery Bankruptcy: Liquidation 00è0 00000000 00.0
Inversago Pharma 25-Jul-2018 00000 00000 00.000 Drug Discovery Clinical Trials - Phase 2 000000 000000 00.0
SemaThera 21-Mar-2018 00000 00000 00.00 Biotechnology Pre-Clinical Trials 000000000 00000000 00.0
SpecificiT Pharma 23-Aug-2017 0000 00000 000 Biotechnology Out of Business 00è0 00000000 00.0
SemaThera 11-Jan-2017 0000 00000 000 Biotechnology Pre-Clinical Trials 000000000 00000000 00.0
Corbin Therapeutics 05-Jan-2017 Seed Round 00000 Biotechnology Startup 000000000 00000000 00.0
Mperia Therapeutics 12-Sep-2016 Early Stage VC 00000 Drug Discovery Out of Business 000000000 00000000 00.0
You’re viewing 10 of 91 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GeneChem Exits (54)

Company Name Exit Date Exit Type Exit Size
Inversago Pharma 08-Sep-2023 Merger/Acquisition 00.000
Mperia Therapeutics 31-Dec-2021 0000000000: 000000
MyX Therapeutics 31-Dec-2021 0000000000: 000000
SpecificiT Pharma 31-Dec-2021 0000000000: 000000
NuChem Sciences 22-Feb-2019 0000000000
Sorbent Therapeutics 01-Jan-2018 0000000000: 000000
Viron Therapeutics 01-Jan-2018 000 00 00000000
Ocera Therapeutics 01-Dec-2017 000000000000000000 00000
AmpliPhi Biosciences 03-Feb-2017 Secondary Transaction - Open Market
Koronis Pharmaceuticals 01-Sep-2016 Merger/Acquisition
You’re viewing 10 of 54 exits. Get the full list »

GeneChem Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

GeneChem Management, Team & Partners (11)

Name Title Deals Funds Boards Office
Louis Lacasse General Partner 0 0 Montreal, Canada
Martial Lacroix Ph.D General Partner 0 0 Montreal, Canada
Inès Holzbaur Ph.D General Partner 0 0 0 Montreal, Canada
You’re viewing 3 of 11 team members. Get the full list »

GeneChem Co-Investors (13)

Name With Exits Lead Partner Series Industry
AQC Capital 2 0 0 Series chart Industry bar
Anges Québec 0 0 0 Series chart Industry bar
Fonds de solidarite FTQ 0 0 0 Series chart Industry bar
Genesys Capital 0 0 0 Series chart Industry bar
adMare BioInnovations 0 0 0 Series chart Industry bar
You’re viewing 5 of 13 co-investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »